1,616 results on '"Basch, Ethan"'
Search Results
2. Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)
3. Patient-Reported Tolerability in Oncology Drug Development
4. Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39)
5. Scoping review of values elicitation tools for treatment decisions in hepatocellular carcinoma
6. A Qualitative Study of Electronic Patient-Reported Outcome Symptom Monitoring After Thoracic Surgery
7. Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable
8. Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium
9. Clinical Decision Support for Surgery: A Mixed Methods Study on Design and Implementation Perspectives From Urologists
10. Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data
11. National Implementation of an Artificial Intelligence–Based Virtual Dietitian for Patients With Cancer
12. Understanding health-related quality of life measures used in early-stage non-small cell lung cancer clinical trials: A review
13. Comparing the Effectiveness of Electronic Symptom Monitoring versus Usual Care in Improving Survival among Patients with Metastatic Cancer -- The PRO-TECT Trial
14. An eHealth symptom and complication management program for cancer patients with newly created ostomies and their caregivers (Alliance): a pilot feasibility randomized trial
15. Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation Therapy
16. Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study
17. Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2
18. The role of the estimand framework in the analysis of patient-reported outcomes in single-arm trials: a case study in oncology.
19. Patient-Perceived Benefits and Limitations of Standard of Care Remote Symptom Monitoring During Cancer Treatment.
20. Impact of real-world remote symptom monitoring program on hospitalizations and ICU admissions.
21. Comparison of symptom clusters between Black and White patients with cancer within an electronic patient-reported outcome remote symptom monitoring program.
22. Patient and provider perceptions of the benefits and limitations of implementing ePRO-driven remote symptom monitoring into real-world cancer care settings.
23. Trajectory of symptoms reported in remote symptom monitoring over the course of oncology treatment for lung cancer.
24. Pain severity among Black and White patients with cancer within a remote symptom monitoring program using electronic patient-reported outcomes.
25. Engagement Among Diverse Patient Backgrounds in a Remote Symptom Monitoring Program.
26. Evaluating the implementation and impact of navigator-supported remote symptom monitoring and management: a protocol for a hybrid type 2 clinical trial
27. A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer
28. The impact of self-reported social determinants of health (SDOH) on patient engagement and symptom burden across a remote patient monitoring (RPM) pathway in 42 European hospitals.
29. National implementation of an AI-based virtual dietitian for patients with cancer.
30. SAT-476 Development of a preference elicitation tool for treatment choice in unresectable, early/intermediate stage HCC
31. PD40-05 GIST OVERRIDES NUMERIC RISK PERCEPTION IN SURGICAL DECISION-MAKING
32. Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: A nested cohort within the PRO-TECT pragmatic trial (AFT-39)
33. A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer
34. Racial differences in user experiences and perceived value of electronic symptom monitoring in a cohort of black and white bladder and prostate cancer patients
35. Comparing Two Types of Blood Thinners to Prevent Blood Clots in Patients with Cancer – The CANVAS Trial
36. The association between patient experience and healthcare outcomes using SEER-CAHPS patient experience and outcomes among cancer survivors
37. Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials
38. Adaptation of Remote Symptom Monitoring Using Electronic Patient-Reported Outcomes for Implementation in Real-World Settings
39. Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: feasibility and clinical relevance.
40. Home Time Among Older Adults With Acute Myeloid Leukemia Following Chemotherapy.
41. Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC)
42. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium
43. [Special issue PRO] Considering endpoints for comparative tolerability of cancer treatments using patient report given the estimand framework
44. Benefits of Breast Cancer Screening and Treatment on Mortality
45. Use of Patient-Reported Outcomes to Understand & Measure the Patient Experience of Novel Cell and Gene Therapies
46. Methods for Developing Patient-Reported Outcome-Based Performance Measures (PRO-PMs)
47. Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study
48. eSyM: An Electronic Health Record–Integrated Patient-Reported Outcomes–Based Cancer Symptom Management Program Used by Six Diverse Health Systems
49. Cost-Effectiveness of Web-Based Patient-Reported Outcome Surveillance in Patients With Lung Cancer
50. Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.